Effects of the Oral Direct Thrombin Inhibitor Ximelagatran on P-Selectin Expression and Thrombin Generation in Atrial Fibrillation

Publisher： Karger

E-ISSN： 1424-8840|33|2|68-74

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.2, 2003-11, pp. : 68-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations

By  

ANAESTHESIA, Vol. 59, Iss. 8, 2004-08 ,pp. : 803-810

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Overview of the Direct Thrombin Inhibitor Argatroban

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2003-06 ,pp. : 9-14

Karger

Access to resources Recommend Favorite

Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 1115-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ximelagatran for stroke prevention in atrial fibrillation

By Salam Amar M  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 49-52

Future Medicine

Access to resources Recommend Favorite

Factor VIII Inhibitor-Bypassing Agents Act by Inducing Thrombin Generation and Can Be Monitored by a Thrombin Generation Assay

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 1, 2003-08 ,pp. : 16-22

Karger

Access to resources Recommend Favorite